101 related articles for article (PubMed ID: 2190380)
21. Comment on cyclosporine assay techniques: an attempt for recommendations.
Rosenthaler J; Keller HP
Transplant Proc; 1990 Jun; 22(3):1160-5. PubMed ID: 2349679
[No Abstract] [Full Text] [Related]
22. Adjustment of cyclosporine dosage in renal transplant patients based on concentration measured specifically in whole blood: clinical outcome results and diagnostic utility.
Shaw LM; Audet PR; Grossman RA; Fields L; Lensmeyer GL; Dafoe DC
Transplant Proc; 1990 Jun; 22(3):1267-73. PubMed ID: 2349688
[No Abstract] [Full Text] [Related]
23. Clinical transplantation--overview.
Beveridge T
Prog Allergy; 1986; 38():269-92. PubMed ID: 3523492
[No Abstract] [Full Text] [Related]
24. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K
Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
[No Abstract] [Full Text] [Related]
25. Japanese conference on cyclosporine blood level monitoring.
Takagi H; Uchida K
Transplant Proc; 1990 Jun; 22(3):1224-5. PubMed ID: 2190384
[No Abstract] [Full Text] [Related]
26. Clinical evaluation and therapeutic range of cyclosporine A as monitored by FPIA in kidney transplantation.
Nattermann U; Steimer W; Gokel JM; Seidel D; Land W
Transplant Proc; 1990 Jun; 22(3):1284-6. PubMed ID: 2190391
[No Abstract] [Full Text] [Related]
27. Summary on therapeutic drug monitoring for renal transplantation.
Kahan BD
Transplant Proc; 1990 Jun; 22(3):1348-51. PubMed ID: 2190398
[No Abstract] [Full Text] [Related]
28. Immunologic significance of hepatocytes in tolerance induction after liver transplantation.
Nakano H; Nakajima Y; Segawa M; Kanehiro H; Murao Y; Nakagawa K; Shiratori T
Transplant Proc; 1987 Feb; 19(1 Pt 1):511-3. PubMed ID: 3274815
[No Abstract] [Full Text] [Related]
29. Histologic response to OKT3 therapy for hepatic allograft rejection.
Rohrer RJ; Jenkins RL; Khettry U; Benotti PN; Dodson TF; Karlson CG; Georgi BA; Monaco AP
Transplant Proc; 1987 Feb; 19(1 Pt 3):2459-61. PubMed ID: 3079086
[No Abstract] [Full Text] [Related]
30. Therapeutic cyclosporine monitoring: comparison of radioimmunoassay and high-performance liquid chromatography methods in organ transplant recipients.
Hirvisalo EL; Kivistö KT; Neuvonen PJ
Ther Drug Monit; 1990 Jul; 12(4):353-8. PubMed ID: 2396309
[TBL] [Abstract][Full Text] [Related]
31. Potential for CsA-Neoral in organ transplantation.
Levy G; Grant D
Transplant Proc; 1994 Oct; 26(5):2932-4. PubMed ID: 7940926
[No Abstract] [Full Text] [Related]
32. Application of the EMIT cyclosporine assay to the Technicon Axon System.
LeGatt DF; Chooi M; Simpson AI; Yatscoff RW
Transplant Proc; 1994 Oct; 26(5):2811-3. PubMed ID: 7940884
[No Abstract] [Full Text] [Related]
33. Preliminary evaluation of a new chemiluminescence assay (Liaison Cyclosporine; DiaSorin Laboratories) allowing both C0 and C2 cyclosporine levels determination: comparison with RIA method.
Olejnik Y; Elaerts S; Bonardet A; Chong G; Mourad G; Cristol JP; Dupuy AM
Transplant Proc; 2005; 37(1):172-4. PubMed ID: 15808584
[TBL] [Abstract][Full Text] [Related]
34. Analysis of cyclosporin A (CsA) concentrations by fluorescence polarization immunoassay (FPIA): comparison with radio immunoassay (RIA) and liquid chromatography (HPLC).
Mraz W; Müller C; Molnar B; Knedel M
Transplant Proc; 1989 Feb; 21(1 Pt 1):885-7. PubMed ID: 2650289
[No Abstract] [Full Text] [Related]
35. OKT3 antibody response study: comparative testing of human antimouse antibody.
Kimball JA; Norman DJ; Shield CF; Schroeder TJ; Lisi P; Garovoy M; O'Connell JB; Stuart F; McDiarmid SV; Wall W
Transplant Proc; 1993 Apr; 25(2 Suppl 1):74-6. PubMed ID: 8465432
[No Abstract] [Full Text] [Related]
36. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
Simonton SC; Sibley RK; Fryd DS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
[No Abstract] [Full Text] [Related]
37. Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
Sridhar N; Schroeder TJ; Pesce AJ; First MR
Transplant Proc; 1990 Jun; 22(3):1257-9. PubMed ID: 2190387
[No Abstract] [Full Text] [Related]
38. Impact of cyclosporine on the development of immunosuppressive therapy.
Fritsche L; Dragun D; Neumayer HH; Budde K
Transplant Proc; 2004 Mar; 36(2 Suppl):130S-134S. PubMed ID: 15041322
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of T-cell receptor-V region determinants on infiltrating T cells in rejecting and nonrejecting human kidney, liver, and heart allografts.
Ibrahim S; Dawson DV; Elmohsen MA; Elsamannoudy FA; Sanfilippo F
Transplant Proc; 1993 Feb; 25(1 Pt 1):80-3. PubMed ID: 8438488
[No Abstract] [Full Text] [Related]
40. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
Awni WM; Heim-Duthoy K; Kasiske BL
Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
